Ariceum Therapeutics
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Building 79 Robert-rössle-straße., Be...Phone Number
+49 3094893360Website
www.ariceum-therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Ariceum Therapeutics
Founded in 2021, Ariceum Therapeutics is a biotechnology company with a focus on radiopharmaceuticals to treat cancer. The company is headquartered in Berlin, Germany.Explore more
Ariceum Therapeutics Org Chart
AC
Director, Clinical Trial
WH
Director, Quality
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ariceum Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Ariceum Therapeutics launches new products
Ariceum Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Ariceum Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Ariceum Therapeutics
Earning: See what the market has to say on Ariceum Therapeutics recently announced quarterly report
Check out if Ariceum Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Ariceum Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Ariceum Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Ariceum Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ariceum Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ariceum Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ariceum Therapeutics.
Ariceum Therapeutics financials insights
Gather financial insights about Ariceum Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$53.5M
Ariceum Therapeutics Tech Stack
A closer look at the technologies used by Ariceum Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Lateral Move
Executive Move
Executive Moves, Lateral Move
Promotion
Executive Move
Executive Moves, Promotion
Ariceum Therapeutics News & Media
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programs Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programsAriceum Therapeutics Data at the 2025 European Association of Nuclear Medicine Annual Congress Further Supports the Advancement of 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer and Merkel Cell Carcinoma
Oral presentation by Dr Zan highlighted novel Phase 1/2 SANTANA-225 study design of 225Ac-SSO110 in patients with ES-SCLC or MCCAriceum Therapeutics Appoints David Schilansky as Chief Executive Officer and Announces New Leadership to Advance Next Phase of Development
David Schilansky transitions to CEO, bringing 25 years of company-building, scaling and financing to advance Ariceum’s pipeline of novel radiotherapeuticsU.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy
225Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation follows outstanding preclinical data and FDA IND clearance Phase I/II human trials set to commence...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ariceum Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2021, Ariceum Therapeutics is a biotechnology company with a focus on radiopharmaceuticals to treat cancer. The company is headquartered in Berlin, Germany.... Read More
